Tarsons Products Limited

Tarsons Products Limited is an Indian life sciences company with more than three decades of experience in manufacturing and supplying labware products used across healthcare, pharmaceutical, biotechnology, food and environmental testing. Its product range, spanning consumables, reusables and other labware, covers more than 1,700 stock-keeping units and is sold under its own brand. The company runs multiple manufacturing facilities in West Bengal and has built a distribution network of over 140 authorized distributors, reaching customers in more than 40 countries. It holds a meaningful share of the Indian plastic labware market, which has been growing at a fast pace alongside the broader life-sciences and diagnostics sector. The IPO combined a fresh issue of shares, used mainly to repay borrowings and fund a new manufacturing facility at Panchla in West Bengal, with a larger offer for sale by existing shareholders and investors.

Ahead of the public issue, Tarsons raised about Rs 306 crore from 32 anchor investors at the upper end of the price band, with allocations to large domestic and international institutions including the Government of Singapore, the Monetary Authority of Singapore, First Sentier Investors, PineBridge, the Abu Dhabi Investment Authority, ICICI Prudential, Aditya Birla Sun Life, Nippon Life, Sundaram Mutual Fund, L&T Mutual Fund and Reliance General Insurance.